EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanotechnology as a Catalyst for Reintroducing Abandoned or Therapeutically Constrained Antimicrobial Agents: Opportunities and Translational Challenges

Babatunde Ibrahim Olowu iD, Olalekan Toheeb Okewale iD, Abdulhakeem Opeyemi Azeez iD, Shammah Oluwaseyi Adeyemi iD

BioMed Research International · 2026-01 · 2026 (1)

DOI: 10.1155/bmri/9486547 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioMed Research International, online erschienen am 08.11.2026. Verfasst von Babatunde Ibrahim Olowu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA, wsu.edu. Hauptthemen laut MEDLINE: Anti-Infective Agents, Nanotechnology. Die Arbeit nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global rise in antimicrobial resistance, increasing rates of emerging and re‐emerging viral infections, and the persistent burden of fungal and parasitic diseases have intensified the need for alternative anti‐infective therapeutic strategies; a challenge further compounded by the diminishing pipeline of novel therapeutic agents. Historically, numerous compounds showed potent broad‐spectrum activity against bacterial, viral, fungal, and parasitic pathogens but failed to achieve widespread clinical adoption due to significant limitations, including systemic toxicity, poor selectivity, rapid degradation, unfavorable pharmacokinetics, and off‐target host damage. Consequently, many of these promising therapeutic agents were abandoned despite their demonstrated efficacy. Advances in nanotechnology have revitalized interest in these historically neglected compounds by enabling targeted delivery, controlled release, improved biodistribution, and reduced toxicity, offering strategies to improve the therapeutic index of agents once considered clinically impractical. Specifically, this review examines how nanotechnology can reshape the translational potential of therapeutically constrained anti‐infective agents and highlights key examples, including halogen‐based antimicrobials, metal‐derived therapeutics, reactive oxygen and nitrogen species, and membrane‐active compounds. We discuss how these technologies address historical barriers to therapeutic application and critically evaluate the remaining barriers hindering clinical translation and long‐term biological interactions. Collectively, we propose that the next generation of anti‐infective therapeutics may emerge not solely from discovering entirely new compounds, but from strategically reengineering abandoned agents using advanced nanotechnology‐enabled delivery systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Infective AgentsNanotechnologyHumansAnimalsDrug Delivery Systems

Stichwörter der Autor:innen

anti-infective therapeuticsdrug delivery systemsdrug repurposingnanomedicinenanotechnologytargeted drug deliverytranslational therapeutics

Substanzen

Anti-Infective Agents

Autor:innen und Institutionen

  • Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA, wsu.edu.
  • Department of Veterinary Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria, ui.edu.ng.
  • Department of Veterinary Microbiology, Faculty of Veterinary Medicine, University of Ilorin, Ilorin, Nigeria, unilorin.edu.ng.
  • Department of Veterinary Biochemistry, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria, ui.edu.ng.

ORCID-Profile: Babatunde Ibrahim Olowu, Olalekan Toheeb Okewale, Abdulhakeem Opeyemi Azeez, Shammah Oluwaseyi Adeyemi

Zitieren

APA

Olowu, B. I., Okewale, O. T., Azeez, A. O., & Adeyemi, S. O. (2026). Nanotechnology as a Catalyst for Reintroducing Abandoned or Therapeutically Constrained Antimicrobial Agents: Opportunities and Translational Challenges. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/9486547

Vancouver

Olowu BI, Okewale OT, Azeez AO, Adeyemi SO. Nanotechnology as a Catalyst for Reintroducing Abandoned or Therapeutically Constrained Antimicrobial Agents: Opportunities and Translational Challenges. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/9486547

BibTeX
@article{Olowu2026,
  author = {Olowu, Babatunde Ibrahim and Okewale, Olalekan Toheeb and Azeez, Abdulhakeem Opeyemi and Adeyemi, Shammah Oluwaseyi},
  title = {Nanotechnology as a Catalyst for Reintroducing Abandoned or Therapeutically Constrained Antimicrobial Agents: Opportunities and Translational Challenges},
  journal = {BioMed Research International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/bmri/9486547}
}
Kostenlos starten →